Han Tianran, Xi Rui, Wang Jialin, Yan Huiqian, Li Linhua
Sports Rehabilitation Research Center, China Institute of Sport Science, Beijing, China.
Front Physiol. 2024 Jul 19;15:1413038. doi: 10.3389/fphys.2024.1413038. eCollection 2024.
The Fibromyalgia Syndrome (FMS) is a multifaceted chronic pain disorder that exerts a substantial impact on the overall state of health and quality of life of patients.
Investigate the effects of exercise therapy and adherence to the American College of Sports Medicine (ACSM) guidelines on treatment outcomes in FMS patients.
The literature search, which concluded in October 2023, encompassed studies investigating the impact of exercise interventions on patients diagnosed with FMS and providing adequate data for calculating standardized mean difference (SMD). The primary outcome measures encompassed the Fibromyalgia Impact Questionnaire (FIQ) and Health Assessment Questionnaire (HAQ), while secondary outcome measures comprised pain levels, sleep quality, fatigue, and mental health.
Among 4,008 records, 19 studies (patients = 857) were eligible for qualitative synthesis. The meta-analysis revealed that the SMD for overall state of health impact was -0.94 (95%CI -1.26, -0.63), and the pooled SMD for the subgroup with high adherence to ACSM guidelines was -1.17 (95%CI -1.65, -0.69). The SMD for the subgroup with low or uncertain adherence was -0.73 (95%CI -1.12, -0.34). The overall effects included a -1.21 (95%CI -1.62, -0.79) SMD for pain relief, with high adherence achieving a -1.32 (95%CI -2.00, -0.64) SMD and low adherence a -1.06 (95%CI -1.55, -0.57) SMD. Mental health improvements showed a -0.95 (95%CI -1.32, -0.57) overall SMD, with high and low adherence subgroups at -0.96 (95%CI -1.62, -0.30) and -0.94 (95%CI -1.29, -0.60), respectively. Sleep quality impact was -1.59 (95%CI -2.31, -0.87) overall, with high adherence at -1.71 (95%CI -2.58, -0.83) and low adherence at -1.11 (95%CI -1.88, -0.33). Fatigue impact had a -1.55 (95%CI -2.26, -0.85) overall SMD, with -1.77 (95%CI -3.18, -0.36) for high adherence and -1.35 (95%CI -2.03, -0.66) for low adherence.
Exercise therapy can improve the overall state of health, pain, sleep, and fatigue of FMS patients, particularly when adhering to ACSM guidelines. However, adherence levels do not affect mental health gains, indicating a need for future research on psychological impact.
https://inplasy.com/inplasy-2024-3-0106/, identifier INPLASY202430106.
纤维肌痛综合征(FMS)是一种多方面的慢性疼痛疾病,对患者的整体健康状况和生活质量产生重大影响。
研究运动疗法以及遵循美国运动医学学院(ACSM)指南对FMS患者治疗效果的影响。
文献检索于2023年10月结束,涵盖了调查运动干预对诊断为FMS患者的影响并提供足够数据以计算标准化均数差(SMD)的研究。主要结局指标包括纤维肌痛影响问卷(FIQ)和健康评估问卷(HAQ),次要结局指标包括疼痛水平、睡眠质量、疲劳和心理健康。
在4008条记录中,19项研究(患者 = 857)符合定性综合分析的条件。荟萃分析显示,对整体健康状况影响的SMD为 -0.94(95%CI -1.26,-0.63),对高度遵循ACSM指南亚组的合并SMD为 -1.17(95%CI -1.65,-0.69)。对低遵循或不确定遵循亚组的SMD为 -0.73(95%CI -1.12,-0.34)。总体效果包括疼痛缓解的SMD为 -1.21(95%CI -1.62,-0.79),高度遵循时SMD为 -1.32(95%CI -2.00,-0.64),低遵循时为 -1.06(95%CI -1.55,-0.57)。心理健康改善的总体SMD为 -0.95(95%CI -1.32,-0.57),高度遵循和低遵循亚组分别为 -0.96(95%CI -1.62,-0.30)和 -0.94(95%CI -1.29,-0.60)。睡眠质量影响总体为 -1.59(95%CI -2.31,-0.87),高度遵循时为 -1.71(95%CI -2.58,-0.83),低遵循时为 -1.11(95%CI -1.88,-0.33)。疲劳影响的总体SMD为 -1.55(95%CI -2.26,-0.85),高度遵循时为 -1.77(95%CI -3.18,-0.36),低遵循时为 -